Connect reports that Avanti Biosciences Inc. is raising a $35 million Series A funding round to move their compound through Phase 2 trials.
Public source
Publisher name
Public post
Meet Avanti Biosciences, Inc. Avanti Biosciences is working to bring a new treatment for idiopathic pulmonary fibrosis to patients. After a supportive pre-IND meeting wi…
Company
Connect
Building the best innovation ecosystem.
- Industry
- Non-profit Organizations
- Location
- San Diego, US
- Company size
- 51–200 employees
About Connect
Connect is the premier innovation leader for the San Diego region. We ignite our local economy and strengthen our impact and reputation as a global innovation hub. Connect is a speciality center of the San Diego & Imperial Small Business Development Center Network.
See moreLatest activity
Latest activity from Connect
7 signals
Presence & Recognition
Connect is hosting Founders Summit during IDEA Week San Diego on Wednesday, October 21, featuring candid conversations with investors and operators about growing, funding, and scaling.
Presence & Recognition
Connect published the September edition of The Connection featuring an insider look at San Diego's innovation ecosystem.
Presence & Recognition
Connect is hosting Innovation Night at La Jolla Playhouse during IDEA Week on Monday, October 19 at 5:30 PM.
Discover more
Similar signals
Similar public activity from other companies.
Capital & Finance
bioSeedin
bioSeedin reported that NovaGo Therapeutics raised $30 million in a round led by Neurimmune and Pureos for $30 million.
Capital & Finance
EIT Pharma, Inc.
EIT Pharma, Inc. closed an oversubscribed $35 million Series A financing led by Propel Bio Partners with participation from Good Ventures, Arrowtown, and other investors.
Capital & Finance
Portal
Portal was awarded $2M from the National Center for Advancing Translational Sciences (NCATS) to expand applications of Galaxy-i, its high-throughput screening platform.
Capital & Finance
Capital Connect brokered by eXp Commercial
Capital Connect brokered by eXp Commercial reported that AusperBio received $120M for biopharma.
Capital & Finance
BiotechTV